04.01.03
Zeavision, St. Louis, MO, has received U.S. patent No. RE38,009 for preparations containing certain stereo-isomers of zeaxanthin as a sole detectable isomer. The product is to be packaged for oral ingestion by humans as a therapeutic drug or nutritional supplement.